chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Urticaria
Clinical narrative: Hives; Skin blisters; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09May2021 at 07:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 09May2021 at 21:30, the patient experienced hives and skin blisters. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hives and skin blisters was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Disturbance in attention, Dizziness, Flushing, Lymphadenopathy
Clinical narrative: Sleepy; Dizzy; Heavy weakness in left arm; Swollen lymph nodes above left clavicle; Flushing at night; Pain shooting up neck on left side; Still weakness; Not as alert/very disturbing; This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 70-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on an unspecified date in 2021 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer from 2009 and known allergies to sulfa and derma bond. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (DIOVAN) and unspecified statin; both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 13Apr2021, the patient experienced sleepy, dizzy, heavy weakness in left arm, swollen lymph nodes above left clavicle, flushing at night, not as alert, pain shooting up neck on left side that lasted more than a week first and second doses, the patient still had weakness and was very disturbed. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events  sleepy, dizzy, heavy weakness in left arm, swollen lymph nodes above left clavicle, flushing at night, not as alert, pain shooting up neck on left side that lasted more than a week first and second doses, the patient still had weakness and was very disturbed was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain, Somnolence
Clinical narrative: Sleepy; Dizzy; Heavy weakness in left arm; Swollen lymph nodes above left clavicle; Flushing at night; Pain shooting up neck on left side; Still weakness; Not as alert/very disturbing; This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 70-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on an unspecified date in 2021 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer from 2009 and known allergies to sulfa and derma bond. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (DIOVAN) and unspecified statin; both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 13Apr2021, the patient experienced sleepy, dizzy, heavy weakness in left arm, swollen lymph nodes above left clavicle, flushing at night, not as alert, pain shooting up neck on left side that lasted more than a week first and second doses, the patient still had weakness and was very disturbed. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events  sleepy, dizzy, heavy weakness in left arm, swollen lymph nodes above left clavicle, flushing at night, not as alert, pain shooting up neck on left side that lasted more than a week first and second doses, the patient still had weakness and was very disturbed was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 20Apr2021 at 06:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and blood pressure high. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks of vaccination. On 20Apr2021 at 06:15, the patient experienced sore left arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with an unspecified medication for an unknown indication from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore left arm was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Nausea
Clinical narrative: Nausea; Back pain; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 12:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medication within two weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 00:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 08May2021, the patient experienced nausea and back pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea and back pain were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Tremor
Clinical narrative: Shaking; Chills; 101 Fever; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Apr2021 at 13:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 27Apr2021, the patient experienced 4 hours of shaking chills, 101deg fever which lasted for 24 hours before subsiding. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. On 27Apr2021, the patient underwent body temperature test and the result was 101 degrees(unspecified unit). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shaking and chills were resolved on an unknown date in Apr2021,after the duration of 4 hours while the clinical outcome of the event fever was resolved on 28Apr2021, after a duration of 24 hours.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Period after the shot came one week early; Heavy bleeding; Heavy cramping; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Apr2021 at 15:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 04May2021, the patient experienced period after the shot came one week early, heavy bleeding and heavy cramping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period after the shot came one week early, heavy bleeding and heavy cramping was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chest discomfort, Chills, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 07May2021 at 08:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 12Apr2021 at 13:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 20: 00, the patient experienced chills, aches, 101 plus fever and tightness of chest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, aches, 101 plus fever and tightness of chest was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Heart rate, Heart rate increased
Clinical narrative: Usual resting heart rate is 55 bpm. Staring the night of 2nd dose and continuing into the 2nd day, it is 80 to 85 even when lying in bed. Just walking to the bathroom makes it increase to over 100 to 115; Also feeling very drained of energy.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 08May2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) daily 24-hour and daily multivitamin (MANUFACTURE UNKNOWN); both for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0189) via an unspecified route of administration in the left arm on 17Apr2021 at 00:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient usual resting heart rate was 55 bpm. On 08May2021 at 23:30, starting the night of second dose and continuing into the second day, the patient heart rate was 80 to 85 even when lying on the bed and any activity including just walking to the bathroom increased the heart rate to over 100 to 115. (Based on a fitness tracker that was worn constantly) and also felt very drained of energy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heart rate was 80 to 85 even when lying in bed and any activity including Just walking to the bathroom makes it increase to over 100 to 115 and  felt very drained of energy was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Nausea, Retching, Vomiting
Clinical narrative: "I" believe the second dose of the vaccine had an interaction with "my" Vyvanse prescription. The next morning, "I" woke up extremely nauseous; Vomited for 8 hours, vomited on at least 20 different occasions during this time period and ran out of stomach contents before puking bile; Then eventually ran out of that in "my" system before dry heaving; Even just drinking water made me vomit again, so "I" could not eat anything.; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 15:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) 20mg for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 15:00 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. On 25Apr2021 at 10:00, the next morning after vaccination, the patient woke up extremely nauseous and vomited for 8 hours until patient took some anti-nausea medications. The patient vomited on at least 20 different occasions during that time period and ran out of stomach contents before puking bile, then eventually ran out of that in her system before dry heaving. Even drinking water made the patient vomit again, so could not eat anything. The patient believed the second dose of the vaccine had an interaction with her vyvanse prescription. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events nauseous and vomited for 8 hours, vomited on at least 20 different occasions, puking bile, dry heaving and included treatment with unspecified anti-nausea medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely nauseous, vomited for 8 hours, vomited on at least 20 different occasions during this time period and ran out of stomach contents before puking bile, then eventually ran out of that in her system before dry heaving, so that could not eat anything were resolved on an unknown date in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Fever on the next day of 100.2; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. On 05May2021 at 06:00, the patient experienced fever on the next day of 100.2 (unspecified units) and fatigue; lasted 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of events fever on the next day of 100.2 and fatigue were recovered on 06May2021 at 06:00, after the duration of 24 hours.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Fatigue, Heavy menstrual bleeding
Clinical narrative: Since becoming fully vaccinated my body temperature has remained higher/ Now itstands at 97.6 and sometimes up to 97.8 I've felt noticeable more uncomfortably warm the past 2 months.; my last 2 menses have been heavier; I have felt more fatigue then normal during that time; This is a spontaneous report from a contactable nurse, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 28Mar2021, since becoming fully vaccinated, the patient's body temperature had remained higher. Her normal body temperature that she had over the course of her entire life had always been 97.3 (units not specified). Now it stands at 97.6 (units not specified) and sometimes up to 97.8 (units not specified), she had felt noticeable more uncomfortably warm the past 2 months. Second, her last 2 menses have been heavier and she has felt more fatigue then normal during that time. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. On an unknown date, the patient underwent body temperature test and the result was 97.3 unspecified units. On an unknown date in 2021, the patient underwent body temperature and the result was 97.6 unspecified units and 97.8 unspecified units respectively. Therapeutic measures were not taken as a result of the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events since becoming fully vaccinated her body temperature has remained higher/ now it stands at 97.6 and sometimes up to 97.8 she had felt noticeable more uncomfortably warm the past 2 months, last 2 menses have been heavier and have felt more fatigue than normal during that time was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected. .
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Headache, Nausea, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 57-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0175), at the age of 57, via an unspecified route of administration, in right arm, on May 7, 2021, at 13:00, single dose, for COVID-19 immunisation. Medical history not reported. The patient has no known allergies. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medication included Synthroid (levothyroxine sodium), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On May 7, 2021, at 13:30, patient experienced dizziness, lightheadedness, headache, stomach pain, leg pain, sore arm and nausea. The events did not result in doctor/other health care professional office/clinic visit/emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. No therapeutic measures taken as a result of the events. The outcome of dizziness, lightheadedness, headache, stomach pain, leg pain, sore arm and nausea: resolving (at the time of report). No follow-up attempts needed. No further information expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Lethargy, Lymphadenopathy
Clinical narrative: Body aches; Lethargy; Headache; Chills; Swollen lymph node on side shot was received; Diarrhea; Tender arm; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 06May2021 at 16:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included serialize and vitamin d nos (MANUFACTURER UNKNOWN); both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient had body aches, lethargy, headache, chills, swollen lymph node on side shot was received, diarrhea and tender arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, lethargy, headache, chills, swollen lymph node on side shot was received, diarrhea and tender arm was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Body aches; Lethargy; Headache; Chills; Swollen lymph node on side shot was received; Diarrhea; Tender arm; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 06May2021 at 16:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included serialize and vitamin d nos (MANUFACTURER UNKNOWN); both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient had body aches, lethargy, headache, chills, swollen lymph node on side shot was received, diarrhea and tender arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, lethargy, headache, chills, swollen lymph node on side shot was received, diarrhea and tender arm was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Fatigue, Headache, Night sweats
Clinical narrative: Fever; chills; night sweats; body aches; headache; fatigue; huge bruise near injection site, easy bruising; This is a spontaneous report from a non-contactable nurse, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 13:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included ovarian cyst and known allergies to cinnamon. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included cetirizine hydrochloride (ZYRTEC), paracetamol (TYLENOL) and naproxen sodium (ALEVE); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 18Mar2021 at 13:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 03:00, the patient experienced fever, chills, night sweats, body aches, headache the night of the vaccine and fatigue the next 1-2 days and also huge bruise near injection site and easy bruising for 1-2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, night sweats, body aches, headache the night of the vaccine, fatigue the next 1-2 days and huge bruise near injection site/easy bruising for 1-2 weeks was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever; chills; night sweats; body aches; headache; fatigue; huge bruise near injection site, easy bruising; This is a spontaneous report from a non-contactable nurse, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 13:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included ovarian cyst and known allergies to cinnamon. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included cetirizine hydrochloride (ZYRTEC), paracetamol (TYLENOL) and naproxen sodium (ALEVE); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 18Mar2021 at 13:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 03:00, the patient experienced fever, chills, night sweats, body aches, headache the night of the vaccine and fatigue the next 1-2 days and also huge bruise near injection site and easy bruising for 1-2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, night sweats, body aches, headache the night of the vaccine, fatigue the next 1-2 days and huge bruise near injection site/easy bruising for 1-2 weeks was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding, Menstruation irregular
Clinical narrative: Irregular periods (4 with in a two month time frame) plus spotting in between; Irregular periods (4 with in a two month time frame) plus spotting in between; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the left arm on 04Jan2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jan2021, the patient experienced irregular periods (4 with in a two month time frame) plus spotting in between. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events irregular periods (4 with in a two month time frame) plus spotting in between was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical urticaria, Pruritus, Urticaria
Clinical narrative: Dermatographic urticaria on "my" torso and neck; The region will be itchy and when "I" scratch it, it raises into welt like hives where "my" nails were; The region will be itchy and when "I" scratch it, it raises into welt like hives where "my" nails were; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included generalized anxiety disorder, seasonal affective disorder and allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), colecalciferol (VITAMIN D3) and cyanocobalamin (VITAMIN B12); all for unknown indications from unknown dates and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN), azithromycin (ZITHROMAX), minocycline (MANUFACTURER UNKNOWN), doxycycline (MANUFACTURER UNKNOWN), sulfamethoxazole/trimethoprim (BACTRIM) and erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 01May2021, the patient had dermatographic urticaria on her torso and neck, the region would be itchy and when she scratched it, it raised into welt like hives where her nails were. These took about 30 minutes to go away. It was reported that the only change in the past 2 months to cause this was getting the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dermatographic urticaria on "my" torso and neck and the region will be itchy and when "I" scratch it, it raises into welt like hives where "my" nails were was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle strain, Myalgia, Pain
Clinical narrative: About a week after the injection, "I" felt pain in the muscles on the left side of neck. It hurt to turn "my" head to the left/  "I" still feel mild muscle pain down "my" neck and in "my" upper arm. It hurts to put down heavy items.; The pain ran down from "my" neck to triceps. "I" stretched and slept with a neck pillow and was able to turn "my" head after a few days.; It feels like a pulled muscle maybe; This is a spontaneous report from a contactable other healthcare professional, the patient. A 23-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, depression/anxiety and environmental allergy. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN); both for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, about a week after the injection, the patient felt pain in the muscles on the left side of her neck. It hurt to turn her head to the left and the pain ran down from her neck to triceps. She stretched and slept with a neck pillow and was able to turn her head after a few days. She felt mild muscle pain down her neck and in upper arm at the time of report. The patient reported that it hurt to put down heavy items and it felt like a pulled muscle might be, but that was at the injection site. The patient also reported that she never had experienced that before and had not done anything to aggravate that muscle. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events patient felt pain in the muscles on the left side of neck/mild muscle pain down neck and in upper arm, the pain ran down from neck to triceps and felt like a pulled muscle was resolving at the time of the report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pyrexia
Clinical narrative: Dizziness several hours after shot, has been on and off for several day; last night nausea and fever; last night nausea and fever; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 07May2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history included high blood pressure, thyroid issues and allergy to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 18:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, several hours after the vaccination, the patient experienced dizziness which had been on and off for several days and last night from the day of report the patient also had nausea and fever. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness, nausea and fever were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Pyrexia
Clinical narrative: Wednesday afternoon "I" started coughing; To much mucus coming in to "my" mouth continuously. the mucus coming from the back of "my" nose is very salty.; "I" got the second dose vaccination Monday April 12 and "I" got sick; High fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunisation. On 13Apr2021, after the second dose of the vaccination on 12Apr2021, the patient got sick with high fever and chills on Tuesday. Wednesday afternoon (14Apr2021 at 07:00 she started coughing and too much mucus was coming  into her mouth continuously and the mucus coming from the back of her nose was very salty. On 10May2021(on the day of this report), she was still going through the same problem. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 13Mar2021, the patient underwent Nasal Swab, SARS CoV-2 test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events got sick, high fever, chills, coughing and too much mucus coming in to mouth continuously, the mucus coming from the back of the nose was very salty were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness, Hyperhidrosis, Lymphadenopathy, Panic attack
Clinical narrative: Swollen lymph node under chin 1 week after first dose; Panic attack; Anxiety; Sweating; Lightheaded; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03May2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021, the patient experienced panic attack, anxiety, sweating, lightheaded immediately after the shot and on 10May2021,  the patient experienced swollen lymph node under chin 1 week after first dose. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events panic attack, anxiety, sweating, lightheaded and swollen lymph node under chin were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Menstruation irregular, Pruritus
Clinical narrative: Breast were getting sore; Entire body itchy; One week after my first shot I started my period.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 13:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05May2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication taken within two weeks of vaccination was not reported. On 17Apr2021, a few days after the shot the patient experienced breast were getting sore and then one week after her first shot, she started her period. The second dose she received on 5May2021 and a few days after her breasts are sore again and expect to start another period in a few days. Each shot additionally made her entire body itchy for a few hours after. She had zero known allergies. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken for the events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events entire body itchy was resolved on an unknown date of Apr2021.The clinical outcome of the event breast was getting sore and one week after her first shot, she started her period was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Retching, Vomiting
Clinical narrative: Chill before bed; Threw up and dry heaved for 4 hours.; Threw up and dry heaved for 4 hours.; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm (also reported as left shoulder) on 08May2021 at 11:15 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included, ethinylestradiol/ferrous fumarate/norethisterone acetate (LOESTRIN FE) and spironolactone (MANUFACTURER UNKNOWN) and unspecified multivitamin; all for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 08May2021 at 23:30 the patient experienced chill before bed, threw up and dry heaved for 4 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events threw up and dry heaved for 4 hours was resolved on 09May2021 at 03:30, while that of the event chill before bed was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.